Ingalls & Snyder LLC Omeros Corp Transaction History
Ingalls & Snyder LLC
- $3.04 Billion
- Q1 2025
A detailed history of Ingalls & Snyder LLC transactions in Omeros Corp stock. As of the latest transaction made, Ingalls & Snyder LLC holds 3,977,813 shares of OMER stock, worth $14.3 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
3,977,813
Previous 4,007,868
0.75%
Holding current value
$14.3 Million
Previous $39.6 Million
17.43%
% of portfolio
1.08%
Previous 1.55%
Shares
31 transactions
Others Institutions Holding OMER
# of Institutions
151Shares Held
27.9MCall Options Held
369KPut Options Held
697K-
Black Rock Inc. New York, NY4.1MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$11.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.94MShares$6.98 Million0.02% of portfolio
-
Stifel Financial Corp St. Louis, MO1.56MShares$5.6 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.37MShares$4.93 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $226M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...